Oncolytics Biotech Inc. (ONCY)
$0.56+3.70%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $56M
- Beta
- 1.15
- P/E (TTM)
- -2.47
- Short % float
- 6.31%
- Days to cover
- 7.2
- SI change
- -14.7%
- 1W
- -11.11%
- 1M
- -27.27%
- vs SPY 1W
- -12.27%
- vs SPY 1M
- -30.26%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ONCY?
- LOPJLB’s latest quantitative signal on Oncolytics Biotech Inc. (ONCY) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ONCY in?
- Oncolytics Biotech Inc. (ONCY) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Oncolytics Biotech Inc. (ONCY) do?
- Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal ad…